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USE OF A SURGICAL HEMOSTAT MODULATES PROPERTIES OF CLOT
ASSOCIATED WITH SUBCHONDRAL BONE MICRODRILLING IN AN
OVINE MODEL FOR CARTILAGE REPAIR
M. Long y, M. Hawkins z. y Stryker Orthobiologics, Mahwah, NJ, USA;
z Stryker Joint Preservation, Mahwah, NJ, USA
Purpose: Since the properties of the clot formed in microfracture
therapy are inﬂuential to clinical outcome, we aimed to evaluate
whether the use of a surgical hemostat (SH) to control bleeding and
augment and stabilize the microfracture clot would improve the clot
properties in the cartilage defects.
Methods: Twenty sheep were operated and cared for at Thomas D.
Morris (Reisterstown, MD) under IACUC approval #12-038 and GLP
quality controls. Two full thickness chondral defects were created in the
distal part of the femur: one 8mmx10mm in the medial femoral con-
dyle; one 6mmx12mm in the trochlea. Each defect was treated by
microfracture/microdrilling (MFX - MicroFX OCD, Stryker) and alter-
natively treated with a surgical hemostat containing autologous
plasma, pepsinized microﬁbrillar collagen and recombinant thrombin
(SH - VITAGEL RT Surgical Hemostat, Stryker). The hemostat was
prepared individually for each treated defect per manufacturer’s
instructions for use. SH was applied to the defect once a bleeding bed
was achieved at the bottom of the defect in sufﬁcient volume (z0.2-
0.4cc) to ﬁll the entire defect, and was then allowed to congeal. Time to
hemostasis when bleeding stopped was measured starting at the time
when the hemostat was applied. The joint was closed once bleeding /
oozing was completely stopped. The sheep were placed in a Thomas
splint for 2 week post-op. Clot/cartilage ﬁll was visually evaluated (non-
instrumented). Clot/cartilage stiffness was assessed semi-quantitatively
using a ﬂexible #10 scalpel blade probewith a 0-4 scoring relative to the
surrounding intact cartilage. Time 0 and 2 weeks clots were carefully
harvested from the defects and sliced in three samples, when allowed
by the size of the clot samples, for subsequent histology/histochemistry,
biochemistry (ELISA for GAG, COL I & II), and DNA/Cellularity (RT-PCR
for COL I & II, Aggrecan) evaluations. For clot and cartilage histology/
histochemistry, frozen and decalciﬁed sections, respectively, were
processed and slides stained with H&E and Safranin-O, and immunos-
tained for Collagen I and II.
Results: Subchondral bone bleeding/marrow stimulation was achieved
in all defects. Time to hemostasis was signiﬁcantly reduced by 52%
when SH was used with MFX (369 vs. 776 seconds, p < 0.01). SH clots
were signiﬁcantly stiffer once hemostasis was achieved (Time 0, 1.9 vs.
1.0, p < 0.001), continued trending to greater stiffness 2 weeks post-op,
with no difference at 24 weeks (Fig. 1). Defect ﬁll was signiﬁcantly
increased 2 weeks post-op when SH was applied (64% vs. 49%, p < 0.05,
Fig. 2), but no difference was observed at 24 weeks. After 2 weeks,
visually, the majority of SH clots appeared glossy white, suggesting
ﬁbrocartilage formation. Overall clot histology at 2 weeks showed
preliminary, incomplete maturation of the clot with no apparent
organized structure, as expected after this short in vivo period. One SH
sample histologically exhibited a substantial matrix formationsurrounding cells with evidence of lacunae formation and evidence of
collagen II formation, suggesting the early stage of ﬁbrocartilage for-
mation (Fig.3). Biochemistry analysis was overall inconclusive. RT-PCR
analysis showed an increase in Collagen I, and to a lesser extent in
Collagen II, after 2 weeks in vivo. When samples were compared in the
same animals (N ¼ 2), the SH group exhibited higher Collagen I and II
signal intensity than the MFX group. Aggrecan analysis was incon-
clusive, as well as the 24 weeks results. After 24 weeks, visually, all
defects appeared mostly ﬁlled with a glossy white tissue comparable to
the untouched surrounding cartilage, suggesting cartilage formation.
The trochlea defects exhibited a higher degree of ﬁll than the condyle
defects. No distinct difference was observed between the two groups at
this late stage of cartilage repair. Histology/histochemistry evaluations
will be used to detect any micro-differences between the two groups.
Conclusions: Under the conditions of the present animal study, the use
of a surgical hemostat containing autologous plasma, pepsinized
microﬁbrillar collagen, and recombinant thrombin in microfracture/
microdrilling defects provided hemostasis but also suggested improved
properties of the clot towards the early stage of cartilage repair. While
microdrilling alone resulted in some positive outcome due to sub-
stantial and uniform bleeding for all defects, the amount of clot tissue in
the defect, clot stiffness, clot biochemistry and cellular organization
were all improved in the early stage of cartilage repair when the
hemostat was used.
Figure 1. Clot stiffness (semi-quantitative) at Time 0, 2, and 24 weeks for
both MFX and SH groups.
Figure 2. Defect Fill (non-instrumented visual evaluation) observed after
2 and 24 weeks in vivo.
Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489S154Figure 3. Histology (Safranin O staining) of one unique SH clot sample
showing matrix formation surrounding cells (red stain) with evidence of
lacunae formation after 2 weeks in vivo.
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CARTILAGE TISSUE ENGINEERING: ADULT HUMAN MESENCHYMAL
STROMAL CELLS AND COLLAGEN BIOMATERIALS
C. Sanjurjo-Rodríguez y,z, A.H. Martínez Sanchez y,
T. Hermida-Gomez y, I.M. Fuentes y,z, J. Bujan x, F.J. De Toro z,
S. Díaz-Prado y,z, F.J. Blanco; y. y INIBIC- Univ. Hosp. of A Coru~na (CHUAC),
A Coru~na, Spain; z INIBIC Dept. of Med., Univ. of A Coru~na, A Coru~na, Spain;
xDept. of Med. Specialties, Univ. of Alcala de Henares, Madrid, Spain
Purpose: The purpose was to study chondrogenesis of adult human
Mesenchymal Stromal Cells, isolated from bone marrow (hBMSCs),
when culture on collagen (Col) biomaterials and to evaluate the suit-
ability of the neotissue formed to use in Tissue Engineering.
Methods: hBMSCswere culturedduring30days inchondrogenicmedium
with Transforming growth factor b-3 (TGFb-3) on the following bio-
materials: Col I, Col IþCol II, Col Iþ heparan sulphate (HS), Col IþCol IIþ
heparan sulphate (HS), Col IþCol IIþ chondroitin sulphate (CHS) and Col
Iþ heparin (OLH3).
We have tested growth and cell morphology on the constructs by histo-
chemical and Scanning (SEM) and Transmission (TEM) Electron Micro-
scopy. Chondrogenic differentiationwas evaluated in all the constructs by
histochemical and immunohistochemistry analyses and molecular biol-
ogy.Moreover, Col concentrationwasmeasured in supernatants along the
culture.
Results: Histology showed that hBMSCs have grown through the scaf-
folds, being the cell percentage respect to the total area of the scaffold:
>75% in Col I, Col IþCol II, Col IþHS, Col IþCol IIþHS, Col IþCol IIþCHS;<
50% in Col IþOLH3. It was observed a big amount of extracellular matrix
(ECM), except in Col IþOLH3. ECM from Col IþCol II and Col IþHS showed
the higher metachromasia for Safranin O proteoglycan staining, whereas
Col I, Col IþCol IIþHS, Col IþCol IIþCHS showed an intermediate meta-
chromasia (Figure). Col II immunostainingwas highly positive in Col I and
Col IþHS ECM and positive intracellularly in Col IþCol II, Col IþCol IIþ HS,
Col IþCol IIþCHS (Figure). Col IþOLH3 did not show positivity for pro-
teoglycans and Col II. By measurement of relative expression levels (REL),
COL II gene expression was seen in cells all over the biomaterials, Col I
(0.63 REL), Col IþCol II (1.00 REL), Col IþHS (0.47 REL), Col IþCol IIþHS
(0.93 REL), Col IþCol IIþCHS (3.57 REL) and Col IþOLH3 (5.20 REL). AGG
gene expressionwas higher in Col IþCol IIþHS (6.47 REL) constructs than
in Col I (0.00 REL), Col IþCol II (0.95 REL),Col IþHS (0.17 REL), Col IþCol
IIþCHS (0.00 REL) and Col IþOLH3 (0.00 REL). TEM analysis showed a bigamount of mitochondria and oval/rounded shape cells (Figure). We could
also see oval/rounded cells and ECM by SEM.
Col released (measured as mg/total volume) was detected in all the
supernatants, ﬁnding the highest concentration in Col IþHS biomaterials
cultures except at day 21: Col I (137.33), Col IþCol II (0.00), Col IþHS (0.00),
Col IþCol IIþHS (3.33), Col IþCol IIþCHS (13.90) and Col IþOLH3 (0.00).
Conclusions: Data showed hBMSCs are able to attach and proliferate on
all Col biomaterials, except in Col IþOLH3. These cells showed abundant
ECM. Analysis showed differentiated cellular phenotype and an ECM
similar to cartilage, inbiomaterials composedbyHS. Theneotissue formed
in the other biomaterials showed an intermediate phenotype. The neo-
tissue formed in Col and HS biomaterials could be useful for cartilage
tissue engineering. Acknowledgements: B. Parma (OPOCRIN S.P.A.); CAM
(S2009/MAT-1472); CIBER BBN CB06-01-0040; Red Gallega de Terapia
Celular (REDICENT); SAI-UDC; CSR is beneﬁciary of a fellowship from
Diputacion de A Coru~na; P. Esbrit (Fundacion Jimenez Díaz).
Figure: Images from the different constructs (columns). Ordered in rows
are shown the different analysis: Scanning (SEM) and Transmission (TEM)
Electron Microscopy, Safranin O staining (SO) and Collagen type II
immunostaining (Col II).
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MRI MORPHOLOGICAL AND QUANTITATIVE EVALUATION OF KNEE
ALLOGRAFT REPAIR AT 3, 6 AND 9 MONTHS POST-OP: EARLY
SURVEILLANCE DEMONSTRATES NASCENT PHYSIOLOGICAL
INCORPORATION OF ALLOGRAFT MATERIAL IN PAIN FREE PATIENTS
J.M. Farber y, B. Holladay z, J. Tamez-Pena x, S. Totterman k, E. Brandser y,
K. Baum k. yQmetrics, Cincinnati, OH, USA; zCommonwealth Orthopaedic
Ctr.s, Edgewood, KY, USA; x Tec de Monterry, Monteryy, Mexico; kQmetrics,
Rochester, NY, USA
Purpose: 1) Morphologically and quantitatively characterize the
appearance and incorporation of allograft material in patients who
are status-post knee articular cartilage (AC) allograft repair; 2) Compare
the characterizations in patients who are pain free with those who
are not.
Methods: Patients undergoing knee AC allograft (Biocartilage) procedures
at our institution receive follow-up MRIs Q three months. All patients are
scanned at 1.5 T (:450W, GE) with a dedicated 8 channel knee coil. Mor-
phological sequences include sagittal 2D PD FSFSE, 3D PD FS FSE and
coronal FSEIR.Quantitative sequences includemulti-echoand two-echoT2
Mapping. In addition, the 3D PD FS FSE sequences are segmented (Qme-
trics), and 3D thickness maps are rendered from the segmented data sets.
The morphological images are assessed for allograft ﬁll, bony edema,
osteophyte formationand the stabilityand integrityof theadjacentAC.The
quantitative data sets are evaluated to assess the degree on allograft
incorporation, speciﬁcally to determine the extent to which the allograft
material has T2 and thickness map values similar or not to the native
cartilage. These results are then correlated with each patient’s pain score
and function. Thus far, eightpatients havehadninemonth follow-upMRIs.
Results: Thus far, all patients’ allografts (N ¼ 8) show good ﬁll morpho-
logically at 3 months; the T2 Map values of the allografts at 3 months all
have higher values relative to the native cartilage - even if the adjacent
native cartilage is diseased - which indicates lower collagen and matrix
organization. At three months, the thickness maps demonstrate good
allograft ﬁll. All patients thus far studied have improved pain scores and
function relative to their pre-operative status. At 6 months, the morpho-
logical and thickness map data show improved allograft ﬁll, with
